FAIRFIELD, Conn. (January 15, 2020)—Convexity Scientific Incorporated (Convexity), provider of consumer-focused respiratory medical technology, announced at CES 2020 its purchase of the digital health assets of Wellinks Incorporated (Wellinks). With this transaction Convexity acquires a portfolio of products and intellectual property, including software to support connected medical devices and remote patient monitoring. Wellinks co-founder and CEO Ellen Su joins the Convexity leadership team as Chief Product Officer.
“We at Wellinks have spent the past several years building connected devices and software with the aim of improving patient quality of life as well as clinical outcomes. By joining Convexity, we can continue to empower patients and improve lives,” said Su. “We are excited to see what the future brings, and how our work paired with Convexity’s excellent team, expertise, and resources can make an impact in digital health.”
Convexity recently closed a Series B financing, led by HighCape Capital. At the time of that announcement, company leadership commented on plans for the funding, including product development, talent acquisition and commercialization.
“This transaction is a key milestone for Convexity and carries forward the impactful work of the legacy Wellinks team. We see a clear opportunity to expand from our hardware focus around Flyp Nebulizer and build digital products that help our consumers to lead healthier lives,” said Geoff Matous, president of Convexity. “Adding the software and connected device expertise of Wellinks will allow us to accelerate in this space. Talent is everything for early-stage companies and we are thrilled to welcome Ellen aboard as a key member of our executive team.”
More than 50 million people in the United States suffer from asthma and chronic obstructive pulmonary disease (COPD), with acute exacerbations of COPD resulting in nearly 1.5 million emergency room visits each year. Designed with the end-user in mind, Convexity Scientific’s Flyp is a pocket-portable nebulizer designed to simplify the management of chronic respiratory conditions. Coined “The Nebulizer Reinvented,” Convexity aims to reshape and improve the entire patient experience.
Digital health technologies have gained significant momentum in recent years. Chronic disease management is one of many segments where providers and payers have encouraged adoption of digital health tools in pursuit of improved outcomes. In 2019, the Centers for Medicare & Medicaid Services incorporated remote patient monitoring services to their physician fee schedule.
Visit flypnebulizer.com and wellinks.com for more information.
